Skip to main content

Tekamlo FDA Approval History

FDA Approved: Yes (Discontinued) (First approved August 26, 2010)
Brand name: Tekamlo
Generic name: aliskiren and amlodipine
Dosage form: Tablets
Company: Novartis Pharmaceuticals Corporation
Treatment for: High Blood Pressure

Marketing Status: Discontinued

Tekamlo (aliskiren and amlodipine) is a direct renin inhibitor and calcium channel blocker combination indicated for the treatment of high blood pressure.

Development timeline for Tekamlo

Aug 27, 2010Approval Novartis receives FDA approval of Tekamlo, a single-pill combination of aliskiren and amlodipine to treat high blood pressure

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.